Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPin-D: Spironolactone in Dialysis-Dependent ESRD
NCT02285920Phase 2Completed
- Sponsor
- University of Pennsylvania
- Start
- Nov 2014
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of spironolactone in end stage renal disease (ESRD), sponsored by University of Pennsylvania. Started Nov 2014; status: completed.
02
Drugs
spironolactone
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02285920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02285920.